A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors
Public ClinicalTrials.gov record NCT04943900. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1 Study of BMS-986416 Alone and in Combination With Nivolumab in Select Solid Tumors
Study identification
- NCT ID
- NCT04943900
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 67 participants
Conditions and interventions
Conditions
Interventions
- BMS-986416 Drug
- Nivolumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 8, 2021
- Primary completion
- Feb 26, 2025
- Completion
- Feb 26, 2025
- Last update posted
- Apr 8, 2025
2021 – 2025
United States locations
- U.S. sites
- 6
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0006 | Atlanta | Georgia | 30322 | — |
| Local Institution - 0005 | Baltimore | Maryland | 21287 | — |
| Local Institution - 0002 | Hackensack | New Jersey | 07601 | — |
| Local Institution - 0013 | Cleveland | Ohio | 44106-1716 | — |
| Local Institution - 0003 | Pittsburgh | Pennsylvania | 15232 | — |
| Local Institution - 0004 | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04943900, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2025 · Synced May 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04943900 live on ClinicalTrials.gov.